TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Japan weighs mixing and matching COVID vaccines
Japan has mostly used COVID-19 vaccines developed by Pfizer or Moderna for its inoculation program. AstraZeneca's vaccine, manufactured in Japan under license, was approved in July for use in people aged 40 or older.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
This creative image taken in a studio in Paris on Monday, showing a syringe and a vaccine vial with the logo of a US biotech firm Moderna, illustrates the announcement of an experimental vaccine against Covid-19 from Moderna that would be nearly 95% effective, marking a second major step forward in the quest to end the Covid-19 pandemic.
(AFP/Joel Saget)
J
apan's health ministry is weighing mixing and matching different COVID-19 vaccines to help ease supply concerns and accelerate the country's inoculation program, the minister in charge of vaccinations said Sunday.
Japan has mostly used COVID-19 vaccines developed by Pfizer or Moderna for its inoculation program. AstraZeneca's vaccine, manufactured in Japan under license, was approved in July for use in people aged 40 or older.
"We can expect an acceleration in vaccinations if we gain approval" for the mixed-dose approach from the Ministry of Health, Labor and Welfare, Taro Kono said in a television program.
As of Thursday, 43.5 percent of the country's population had received two doses.
As for the administration of a third vaccine shot already under consideration in response to reduced efficacy and breakthrough infection cases among fully vaccinated people, Kono said this can be started for health care workers in October at the earliest and for people aged 65 or older in January or February once authorized.
"We have already secured the necessary quantities" for a booster shot rollout, Kono said.
